1.Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor
Chun-Bong SYNN ; Dong Kwon KIM ; Jae Hwan KIM ; Youngseon BYEON ; Young Seob KIM ; Mi Ran YUN ; Ji Min LEE ; Wongeun LEE ; Eun Ji LEE ; Seul LEE ; You-Won LEE ; Doo Jae LEE ; Hyun-Woo KIM ; Chang Gon KIM ; Min Hee HONG ; June Dong PARK ; Sun Min LIM ; Kyoung-Ho PYO
Yonsei Medical Journal 2022;63(1):42-55
Purpose:
Agonists of the stimulator of interferon genes (STING) play a key role in activating the STING pathway by promoting the production of cytokines. In this study, we investigated the antitumor effects and activation of the systemic immune response of treatment with DMXAA (5,6-dimethylxanthenone-4-acetic acid), a STING agonist, in EML4-ALK lung cancer and CT26 colon cancer.
Materials and Methods:
The abscopal effects of DMXAA in the treatment of metastatic skin nodules were assessed. EML4-ALK lung cancer and CT26 colon cancer models were used to evaluate these effects after DMXAA treatment. To evaluate the expression of macrophages and T cells, we sacrificed the tumor-bearing mice after DMXAA treatment and obtained the formalin-fixed paraffin-embedded (FFPE) tissue and tumor cells. Immunohistochemistry and flow cytometry were performed to analyze the expression of each FFPE and tumor cell.
Results:
We observed that highly infiltrating immune cells downstream of the STING pathway had increased levels of chemokines after DMXAA treatment. In addition, the levels of CD80 and CD86 in antigen-presenting cells were significantly increased after STING activation. Furthermore, innate immune activation altered the systemic T cell-mediated immune responses, induced proliferation of macrophages, inhibited tumor growth, and increased numbers of cytotoxic memory T cells. Tumor-specific lymphocytes also increased in number after treatment with DMXAA.
Conclusion
The abscopal effect of DMXAA treatment on the skin strongly reduced the spread of EML4-ALK lung cancer and CT26 colon cancer through the STING pathway and induced the presentation of antigens.
2.Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder.
Hong Jin JEON ; Jong Min WOO ; Hyo Jin KIM ; Maurizio FAVA ; David MISCHOULON ; Seong Jin CHO ; Sung Man CHANG ; Doo Heum PARK ; Jong Woo KIM ; Ikki YOO ; Jung Yoon HEO ; Jin Pyo HONG
Psychiatry Investigation 2016;13(6):609-615
OBJECTIVE: Although somatic symptoms are common complaints of patients with major depressive disorder (MDD), their associations with suicide are still unclear. METHODS: A total of 811 MDD outpatients of aged between 18 to 64 years were enrolled nationwide in Korea with the suicidality module of the Mini-International Neuropsychiatric Interview (MINI) and the Depression and Somatic Symptom Scale (DSSS). RESULTS: On stepwise regression analysis, current suicidality scores were most strongly associated with chest pain in men, and neck or shoulder pain in women. Severe chest pain was associated with higher current suicidality scores in men than in women, whereas severe neck or shoulder pain showed no significant differences between the genders. In conclusion, MDD patients of both sexes with suicidal ideation showed significantly more frequent and severe somatic symptoms than those without. Current suicidal risk was associated with chest pain in men, and neck or shoulder pain in women. CONCLUSION: We suggest that clinicians pay attention to patients' somatic symptoms in real world practice.
Chest Pain
;
Depression
;
Depressive Disorder, Major*
;
Female
;
Humans
;
Korea
;
Male
;
Neck
;
Outpatients*
;
Shoulder Pain
;
Suicidal Ideation
;
Suicide
3.A Study on Reliability and Validity of the Impact of Event Scale-Revised-North Korea (IES-R-NK).
Sung Doo WON ; So Hee LEE ; Jin Pyo HONG ; Jin Yong JUN ; Jeong Mee HAN ; Mi Nyeo SHIN ; Myung Hee AHN ; Taeyeop LEE
Journal of Korean Neuropsychiatric Association 2015;54(1):97-104
OBJECTIVES: This study was conducted to translate the Impact of Event Scale-Revised (IES-R) into North Korean language and confirm its reliability and validity. METHODS: A total of 207 North Korean defectors recruited from the Call Center for North Korean Defectors participated in this study. Psychiatrists and psychiatric residents interviewed the participants individually and made psychiatric diagnosis. Subsequently, they completed the Brief Psychological State Inventory for North Korean Refugees (BPSI-NKR), the Center for Epidemiologic Studies Depression Scale-North Korea (CES-D-NK), and the Alcohol Use Disorders Identification Test-North Korea (AUDIT-NK) as well as the Impact of Event Scale-Revised-North Korea (IES-R-NK). Of the original participants, 143 subjects participated in test-retest reliability study after one week. RESULTS: The internal consistency using Cronbach's alpha was superior in both male and female from North Korea. In addition, the temporal stability was also satisfactory. A good convergent validity was clearly shown by significant correlations with BPSI-PTSD and CES-D-NK, respectively. On the other hand, IES-R-NK had no or weak correlations with AUDIT-NK and BPSI-NKR-alcohol, demonstrating its satisfactory discriminant validity. CONCLUSION: IES-R-NK might be considered as a short and valid screening tool for identification of PTSD symptoms in North Korean defectors.
Democratic People's Republic of Korea
;
Depression
;
Epidemiologic Studies
;
Female
;
Hand
;
Humans
;
Korea
;
Male
;
Mass Screening
;
Mental Disorders
;
Psychiatry
;
Refugees
;
Reproducibility of Results*
;
Stress Disorders, Post-Traumatic
4.The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center.
Kwangzoo CHUNG ; Youngyih HAN ; Jinsung KIM ; Sung Hwan AHN ; Sang Gyu JU ; Sang Hoon JUNG ; Yoonsun CHUNG ; Sungkoo CHO ; Kwanghyun JO ; Eun Hyuk SHIN ; Chae Seon HONG ; Jung Suk SHIN ; Seyjoon PARK ; Dae Hyun KIM ; Hye Young KIM ; Boram LEE ; Gantaro SHIBAGAKI ; Hideki NONAKA ; Kenzo SASAI ; Yukio KOYABU ; Changhoon CHOI ; Seung Jae HUH ; Yong Chan AHN ; Hong Ryull PYO ; Do Hoon LIM ; Hee Chul PARK ; Won PARK ; Dong Ryul OH ; Jae Myung NOH ; Jeong Il YU ; Sanghyuk SONG ; Ji Eun LEE ; Bomi LEE ; Doo Ho CHOI
Radiation Oncology Journal 2015;33(4):337-343
PURPOSE: The purpose of this report is to describe the proton therapy system at Samsung Medical Center (SMC-PTS) including the proton beam generator, irradiation system, patient positioning system, patient position verification system, respiratory gating system, and operating and safety control system, and review the current status of the SMC-PTS. MATERIALS AND METHODS: The SMC-PTS has a cyclotron (230 MeV) and two treatment rooms: one treatment room is equipped with a multi-purpose nozzle and the other treatment room is equipped with a dedicated pencil beam scanning nozzle. The proton beam generator including the cyclotron and the energy selection system can lower the energy of protons down to 70 MeV from the maximum 230 MeV. RESULTS: The multi-purpose nozzle can deliver both wobbling proton beam and active scanning proton beam, and a multi-leaf collimator has been installed in the downstream of the nozzle. The dedicated scanning nozzle can deliver active scanning proton beam with a helium gas filled pipe minimizing unnecessary interactions with the air in the beam path. The equipment was provided by Sumitomo Heavy Industries Ltd., RayStation from RaySearch Laboratories AB is the selected treatment planning system, and data management will be handled by the MOSAIQ system from Elekta AB. CONCLUSION: The SMC-PTS located in Seoul, Korea, is scheduled to begin treating cancer patients in 2015.
Cyclotrons
;
Helium
;
Humans
;
Korea*
;
Metallurgy
;
Particle Accelerators
;
Patient Positioning
;
Proton Therapy*
;
Protons*
;
Radiation Oncology
;
Respiratory System
;
Seoul
5.Statistical Errors in Papers Published in the Journal of the Korean Society for Therapeutic Radiology and Oncology.
Hee Chul PARK ; Doo Ho CHOI ; Song Vogue AHN ; Jin Oh KANG ; Eun Seog KIM ; Won PARK ; Seung Do AHN ; Dae Sik YANG ; Hyong Geun YUN ; Eun Ji CHUNG ; Eui Kyu CHIE ; Hongryull PYO ; Semie HONG
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2008;26(4):289-294
PURPOSE: To improve the quality of the statistical analysis of papers published in the Journal of the Korean Society for Therapeutic Radiology and Oncology (JKOSTRO) by evaluating commonly encountered errors. MATERIALS AND METHODS: Papers published in the JKOSTRO from January 2006 to December 2007 were reviewed for methodological and statistical validity using a modified version of Ahn's checklist. A statistician reviewed individual papers and evaluated the list items in the checklist for each paper. To avoid the potential assessment error by the statistician who lacks expertise in the field of radiation oncology; the editorial board of the JKOSTRO reviewed each checklist for individual articles. A frequency analysis of the list items was performed using SAS (version 9.0, SAS Institute, NC, USA) software. RESULTS: A total of 73 papers including 5 case reports and 68 original articles were reviewed. Inferential statistics was used in 46 papers. The most commonly adopted statistical methodology was a survival analysis (58.7%). Only 19% of papers were free of statistical errors. Errors of omission were encountered in 34 (50.0%) papers. Errors of commission were encountered in 35 (51.5%) papers. Twenty-one papers (30.9%) had both errors of omission and commission. CONCLUSION: A variety of statistical errors were encountered in papers published in the JKOSTRO. The current study suggests that a more thorough review of the statistical analysis is needed for manuscripts submitted in the JKOSTRO.
6.Analysis of 67 malignant salivary gland tumors in Korean population.
Hyunkyung PAI ; Dongheon YEO ; Sun A KIM ; Meera CHOI ; Jae Il LEE ; Sam Pyo HONG ; Seong Doo HONG
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2007;33(2):139-142
Malignant salivary gland tumor is rare neoplasm. In Korean population, retrospective study of malignant salivary gland tumor has not been performed. We analyzed 67 cases of malignant salivary gland tumors from 2001 to 2005 in Seoul National University Dental Hospital in Seoul, Korea. The mean age is 51.7 and the male to female ratio is 1:1.39. The most affected site is the palate. Histologically, the tumors were classified as adenoid cystic carcinoma(34.4%), mucoepidermoid carcinoma(31.3%), adenocarcinoma, NOS(11.9%), polymorphous low grade adenocarcinoma(3.0%), salivary duct carcionoma(6.0%), carcinoma ex pleomorphic adenoma(4.5%), myoepithelial carcinoma(4.5%), epithelial-myoepithelial carcinoma(1.5%), cyatadenocarcinoma(1.5%) and adenosquamous carcinoma(1.5%).
Adenocarcinoma
;
Adenoids
;
Female
;
Humans
;
Korea
;
Male
;
Palate
;
Retrospective Studies
;
Salivary Ducts
;
Salivary Glands*
;
Seoul
7.Dosimetric Verification of Dynamic Conformal Arc Radiotherapy.
Tae Hyun KIM ; Dong Ho SHIN ; Doo Hyun LEE ; Sung Yong PARK ; Myung Guen YUN ; Kyung Hwan SHIN ; Hong Ryull PYO ; Joo Young KIM ; Dae Yong KIM ; Kwan Ho CHO ; Dae Sik YANG ; Chul Yong KIM
Korean Journal of Medical Physics 2005;16(4):166-175
The purpose of this study is to develop the optimization method for adjusting the film isocenter shift and to suggest the quantitative acceptable criteria for film dosimetry after optimization in the dynamic conformal arc radiation therapy (DCAR). The DCAR planning was performed in 7 patients with brain metastasis. Both absolute dosimetry with ion chamber and relative film dosimetry were performed throughout the DCAR using BrainLab's micro-multileaf collimator. An optimization method for obtaining the global minimum was used to adjust for the error in the film isocenter shift, which is the largest part of systemic errors. The mean of point dose difference between measured value using ion chamber and calculated value acquired from planning system was 0.51+/-0.43% and maximum was 1.14% with absolute dosimetry. These results were within the AAPM criteria of below 5%. The translation values of film isocenter shift with optimization were within +/-1 mm in all patients. The mean of average dose difference before and after optimization was 1.70+/-0.36% and 1.34+/-0.20%, respectively, and the mean ratios over 5% dose difference was 4.54+/-3.94% and 0.11+/-0.12%, respectively. After optimization, the dose differences decreased dramatically and a ratio over 5% dose difference and average dose difference was less than 2%. This optimization method is effective in adjusting the error of the film isocenter shift, which is the largest part of systemic errors, and the results of this research suggested the quantitative acceptable criteria could be accurate and useful in clinical application of dosimetric verification using film dosimetry as follows; film isocenter shift with optimization should be within +/-1 mm, and a ratio over 5% dose difference and average dose difference were less than 2%.
Brain
;
Film Dosimetry
;
Humans
;
Neoplasm Metastasis
;
Radiotherapy*
8.Inactivation patterns of p16/INK4A in oral squamous cell carcinomas.
Jeong Keun LEE ; Myung Jin KIM ; Sam Pyo HONG ; Seong Doo HONG
Experimental & Molecular Medicine 2004;36(2):165-171
The p16/INK4A is one of the major target genes in carcinogenesis and its inactivation has frequently been reported in other types of tumors. The purpose of this study is to evaluate inactivation patterns of p16/INK4A in oral squamous cell carcinoma. Six different oral cancer cell lines, SCC-4, SCC-9, SCC-15, SCC-25, KB, and SNUDH- 379 were examined for inactivation of p16/INK4A genes. In the analysis of p16/INK4A gene inactivation, PCR amplification, direct sequencing, and methylation-specific PCR methods were adopted for evaluation of homozygous deletion, point mutation, and promoter hypermethylation, respectively. Homozygous deletion was detected in SCC-25 and SCC-9. SCC-15 showed hypermethylated promoter region within p16/INK4A gene. It is suggestive in the present study that inactivation patterns of p16/INK4A were mainly homozygous deletion, promoter methylation rather than point mutation in oral squamous cancer cell lines, so treatment modalities of oral squamous cell carcinoma should be focused on these types of inactivation.
Carcinoma, Squamous Cell/*genetics
;
Cell Line, Tumor
;
DNA Methylation
;
*Gene Silencing
;
Homozygote
;
Humans
;
Mouth Neoplasms/*genetics
;
Point Mutation
;
Promoter Regions (Genetics)/genetics
;
Protein p16/*genetics
9.Preparation of 125I-Iodotyraminehemisuccinyltaxol ( 125ITHT ) for Competitive Taxol Radioimmunoassay.
Chang Woon CHOI ; Sang Moo LIM ; Ok Doo AWH ; Tae Sup LEE ; Tae Hyun CHOI ; Hyun Suk KIM ; Jun Pyo HONG ; Eun Sook LEE
Korean Journal of Nuclear Medicine 2002;36(2):121-132
No abstract available.
Paclitaxel*
;
Radioimmunoassay*
10.Preparation of 99mTc-HYNIC-PEG-liposomes for Imaging of the Focal Sites of Infection.
Jun Pyo HONG ; Ok Doo AWH ; Hyun Duk KIM ; Eun Sook LEE ; Tae Sup LEE ; Tae Hyun CHOI ; Chang Woon CHOI ; Sang Moo LIM
Korean Journal of Nuclear Medicine 2002;36(6):333-343
No abstract available.

Result Analysis
Print
Save
E-mail